Skip to main content

Table 2 Multivariate logistics analysis for miR-361-5p in ACS patients

From: Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients

Features Multivariate logistics analysis
  OR 95% CI P value
Age 1.228 0.792–1.761 0.742
Gender 1.122 0.807–1.851 0.856
BMI 1.608 0.897–2.341 0.224
TC 1.841 0.908–2.622 0.168
TG 1.908 0.966–3.121 0.077
HDL-C 1.934 0.971–3.257 0.065
LDL-C 2.019 0.982–3.345 0.057
Hypertension 1.755 0.928–2.626 0.234
Diabetes 1.798 0.951–2.974 0.097
WBC 1.713 0.913–2.596 0.276
cTnI 1.858 1.098–2.801 0.047*
Gensini score 2.225 1.749–2.917 0.018*
Drug therapy    
 Antiplatelet therapy 1.371 0.785–2.117 0.457
 Nitrates 1.108 0.804–1.598 0.895
 ACEI/ARB 1.152 0.776–1.853 0.524
 Statins 1.214 0.781–1.779 0.661
 β-blockers 1.089 0.628–1.597 0.735
miR-361-5p 2.485 1.999–3.208 0.012*
  1. miR-361-5p microRNA-361-5p, ACS acute coronary syndrome, OR odds ratio, CI confidence interval, BMI body mass index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, WBC white blood cell, cTnI cardiac troponin I, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker
  2. *P < 0.05